You are here

kidney disease

With industry's growing kidney moment, Everest begins building kidney portfolio

BioCentury

Mon, 06/10/19 - 09:29 am

Everest Medicines

clinical trials

IgA nephropathy

J&J’s Invokana closes on diabetic kidney disease approval

Pharmaforum

Thu, 05/23/19 - 09:50 am

diabetic kidney disease

priority review

Gilead strikes deal with biotech Goldfinch Bio to tackle kidney diseases

Marketwatch

Wed, 05/8/19 - 12:37 pm

Gilead Sciences

drug development

Outracing 2 giant rivals, J&J touts promising PhIII Invokana data as a game-changer for kidney disease risks

Endpoints

Sun, 04/14/19 - 11:58 pm

Achillion Meets Enrollment Target in Kidney Disease Studies

Yahoo/Zacks.com

Thu, 04/4/19 - 12:11 pm

clinical trials

Alexion’s newly approved rare-disease drug notches another clinical trial win

Stat

Mon, 01/28/19 - 11:10 am

Alexion Pharmaceuticals

clinical trials

Release: Vascular Therapies Appoints John McDermott as Chief Executive Officer

CP Wire

Thu, 01/10/19 - 03:26 pm

Vascular Therapies

Using AI to Enhance Kidney Disease Detection

Medical Devices and Diagnostics Industry

Wed, 11/21/18 - 09:56 am

artificial intelligence

Reata’s bardoxolone hits goals in phase 2 kidney disease trial

Fierce Biotech

Tue, 09/25/18 - 09:46 am

clinical trials

$1.3 Billion Merger Between Akebia Therapeutics and Keryx Biopharmaceuticals to Focus on Kidney Disease

CP Wire

Thu, 06/28/18 - 09:30 am

Akebia Therapeutics

$1.3 Billion Merger Between Akebia Therapeutics and Keryx Biopharmaceuticals to Focus on Kidney Disease

Thu, 06/28/18 - 09:23 am

Akebia Therapeutics

ADA: Lilly, BI's Jardiance cut kidney disease progression in Empa-Reg analysis

Fierce Pharma

Mon, 06/25/18 - 09:06 pm

Boehringer Ingelheim

Novo Nordisk licenses kidney disease drug from Epigen

Fierce Biotech

Thu, 05/24/18 - 10:01 am

CVS is diving into the dialysis market

Mass Device

Fri, 04/6/18 - 11:47 am

ACC: Novartis' canakinumab cuts CV risks in patients with kidney disease, diabetes by up to 18%

Fierce Pharma

Tue, 03/13/18 - 11:43 am

Why Achillion Pharmaceuticals, Inc. Stock Spiked Monday

Motley Fool

Mon, 02/26/18 - 07:25 pm

AstraZeneca hauls kidney disease drug into the clinic after handing Ionis $30M in cash, $300M in milestones

Endpoints

Tue, 02/20/18 - 11:07 am

Ionis Pharmaceuticals

Reata buoyed by positive data for kidney disease drug

BioPharma Dive

Mon, 11/6/17 - 08:20 pm

Reata Pharmaceuticals

bardoxolone methyl

Klotho Therapeutics Raises $10M to Test Drug in Kidney Disease

Xconomy

Fri, 11/3/17 - 09:30 am

Klotho Therapeutics

Impax Labs stock surges 4.4% on FDA approval of generic kidney disease medication Renvela

Marketwatch

Tue, 10/24/17 - 09:15 am

Pages